Emmaus Life Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

INVESTMENTS (Details Narrative)

INVESTMENTS (Details Narrative) ₩ / shares in Units, $ / shares in Units, ₩ in Millions				1 Months Ended				3 Months Ended		9 Months Ended
	Sep. 28, 2020 USD ($) $ / shares	Sep. 28, 2020 ₩ / shares	Oct. 31, 2018 USD ($)	Apr. 30, 2023 USD ($)	Apr. 30, 2023 KRW (₩)	Feb. 28, 2022 USD ($)	Feb. 28, 2022 KRW (₩)	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Apr. 30, 2023 KRW (₩)	Dec. 31, 2022 USD ($)	Feb. 28, 2022 KRW (₩)	Dec. 31, 2018 USD ($)
Schedule Of Investments [Line Items]
Call option agreement date	Sep. 28, 2020
Revenue from contract								$ 5,018,000	$ 4,939,000	$ 22,530,000	$ 12,460,000
Realized net loss on investment bond				$ 106,000		$ 126,000
Other income						41,000
EJ Holdings, Inc. [Member]
Schedule Of Investments [Line Items]
Secured debt percentage			1.00%
Investment amount															$ 32,000
Percentage of voting interest															40.00%
Unsecured Long-Term Debt, Noncurrent			$ 13,600,000
Debt instrument, maturity date			Sep. 30, 2028
Unsecured debt, additional borrowings								2,600,000		2,600,000
Financing Receivable, before Allowance for Credit Loss								$ 24,400,000		24,400,000			$ 25,000,000
EJ Holdings, Inc. [Member] \| Japan Industrial Partners [Member]
Schedule Of Investments [Line Items]
Equity method investment, ownership percentage															60.00%
Maximum [Member]
Schedule Of Investments [Line Items]
Percentage of principal amount of convertible bond to be repurchased	50.00%
Telcon, Inc. ("Telcon") [Member]
Schedule Of Investments [Line Items]
Convertible bond maturity date	Oct. 16, 2030
Secured debt percentage	2.10%	2.10%
Convertible bond initial conversion price \| (per share)	$ 8.00	₩ 9,232
Offset amount against principal amount of convertible bond						2,900,000								₩ 3,500
Cash proceeds to shortfall in revenue and profits						$ 310,000	₩ 400
Convertible Bond Purchase Agreement [Member] \| Telcon, Inc. ("Telcon") [Member]
Schedule Of Investments [Line Items]
Purchase of principal amount of convertible bond at face value	$ 26,100,000
API Supply Agreement [Member] \| Telcon RF Pharmaceuticals, Inc. ("Telcon") [Member]
Schedule Of Investments [Line Items]
Offset amount against principal amount of convertible bond				2,200,000								₩ 2,900
Cash proceeds to shortfall in revenue and profits				$ 236,000	₩ 307
API Supply Agreement [Member] \| Telcon RF Pharmaceuticals, Inc. ("Telcon") [Member] \| Minimum [Member]
Schedule Of Investments [Line Items]
Annual revenue										5,000,000
API Supply Agreement [Member] \| Telcon RF Pharmaceuticals, Inc. ("Telcon") [Member] \| Maximum [Member]
Schedule Of Investments [Line Items]
Annual revenue										$ 2,500,000